Mante, Friend Rezel C.
HRN: 20-42-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFTRIAXONE 1G (VIAL)
03/25/2024
04/01/2024
IV DRIP
1g
Q24
Cfc; TC Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes